Modus Advisors, LLC Compugen LTD Transaction History

Modus Advisors, LLC

$305 Million
Q4 2024

A detailed history of Modus Advisors, LLC transactions in Compugen LTD stock. As of the latest transaction made, Modus Advisors, LLC holds 28 shares of CGEN stock, worth $54. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$54

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 03, 2025	BUY	$1.41 - $1.93 $39 - $54	28 New	28 $0
Q3 2021 Oct 08, 2021	SELL	$5.8 - $8.02 $162 - $224	-28 Closed	0 $0
Q2 2021 Jul 01, 2021	BUY	$6.87 - $9.16 $192 - $256	28 New	28 $0

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.4M

Call Options Held

44.9K

Put Options Held

8.1K

Silverarc Capital Management, LLC

1.62M
Shares

$3.15 Million
0.6% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.28M
Shares

$2.48 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.09M
Shares

$2.12 Million
0.85% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.98 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

990K
Shares

$1.92 Million
0.06% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $168M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.

Account